Lilly’s Kisunla Label Update Lowers ARIA-E Risk For Alzheimer’s Patients

Safety Improvement Could Boost Uptake

 
• By Mandy Jackson
  
The updated dose titration schedule gives doctors and patients new risk/benefit considerations (Shutterstock)

More from Neurological

More from Therapy Areas